1 / 1

Clase

Estudio ALMS. Estudio. Clase. Sujetos. Fármacos. Resultados. 1.ALMS. ECA. 370 (C147,A123,O100). MMF vs . IV CYC 3g NHI. No diferencia. 2.Eficacia Raza/étnico. Subanálisis. 370 (C147,A123,O100). MMF vs. IV CYC 3g NHI. Mejor para MMF. 3.Eficacia extrarenal.

portia-carlson
Download Presentation

Clase

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Estudio ALMS Estudio Clase Sujetos Fármacos Resultados 1.ALMS ECA 370 (C147,A123,O100) MMF vs. IV CYC 3g NHI No diferencia 2.Eficacia Raza/étnico Subanálisis 370 (C147,A123,O100) MMF vs. IV CYC 3g NHI Mejor para MMF 3.Eficacia extrarenal Subanálisis 370 (C147,A123,O100) MMF vs. IV CYC 3g NHI No diferencias Meta-análisis Autores Sujetos Fármacos Resultados 1. Mak A, et al. Metaanálisis 10 ECA 847 MMF vs. IV CYC 8 MMF vs. CYC oral 2 Eficacia similar Seguridad favorece MMF 2. Lee YH, et al. Metaanálisis 6 ECA 662 MMF vs. IV CYC 5 MMF vs. CYC oral 1 No diferencias 3. Kamanamool N, et al. Metaanálisis 5 ECA 638 MMF vs. IV CYC No diferencias, menos leucopenia 4.. Toura Z, et al. Metaanálisis 4 ECA 618 MMF vs. IV CYC No diferencias, menos alopecia y amenorrea Clase

More Related